Literature DB >> 10726263

Absence of lipophosphoglycan-like glycoconjugates in Entamoeba dispar.

A Bhattacharya1, R Arya, C G Clark, J P Ackers.   

Abstract

Invasive amoebiasis is the result of infection of Entamoeba histolytica. The closely related Entamoeba dispar can colonize the human gut but does not cause invasive disease. In this study, E. dispar was analysed for the presence of the lipophosphoglycan-like (LPG) glycoconjugate known to be present on the cell surface of E. histolytica. E. dispar cells were radio-isotope labelled with [3H]galactose or [3H]inositol. The acidic glycoconjugates were extracted and analysed by hydrophobic chromatography over phenyl-Sepharose and by sodium dodecyl sulphate polyacrylamide gel electrophoresis. No LPG-like molecules could be identified in E. dispar in contrast to E. histolytica, suggesting that these molecules may be absent in the non-pathogenic species.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10726263     DOI: 10.1017/s0031182099005259

Source DB:  PubMed          Journal:  Parasitology        ISSN: 0031-1820            Impact factor:   3.234


  8 in total

1.  Reduction of cell surface glycosylphosphatidylinositol conjugates in Entamoeba histolytica by antisense blocking of E. histolytica GlcNAc-phosphatidylinositol deacetylase expression: effect on cell proliferation, endocytosis, and adhesion to target cells.

Authors:  Divya Vats; Ram A Vishwakarma; Sudha Bhattacharya; Alok Bhattacharya
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

2.  The antiretroviral lectin cyanovirin-N targets well-known and novel targets on the surface of Entamoeba histolytica trophozoites.

Authors:  Andrea Carpentieri; Daniel M Ratner; Sudip K Ghosh; Sulagna Banerjee; G Guy Bushkin; Jike Cui; Michael Lubrano; Martin Steffen; Catherine E Costello; Barry O'Keefe; Phillips W Robbins; John Samuelson
Journal:  Eukaryot Cell       Date:  2010-09-17

3.  A monoclonal antibody to the amebic lipophosphoglycan-proteophosphoglycan antigens can prevent disease in human intestinal xenografts infected with Entamoeba histolytica.

Authors:  Zhi Zhang; Michael Duchêne; Samuel L Stanley
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

Review 4.  Host-microbe interactions and defense mechanisms in the development of amoebic liver abscesses.

Authors:  Julien Santi-Rocca; Marie-Christine Rigothier; Nancy Guillén
Journal:  Clin Microbiol Rev       Date:  2009-01       Impact factor: 26.132

Review 5.  The dynamic interdependence of amebiasis, innate immunity, and undernutrition.

Authors:  Hans P Verkerke; William A Petri; Chelsea S Marie
Journal:  Semin Immunopathol       Date:  2012-11-01       Impact factor: 9.623

Review 6.  Immune Response of Amebiasis and Immune Evasion by Entamoeba histolytica.

Authors:  Kumiko Nakada-Tsukui; Tomoyoshi Nozaki
Journal:  Front Immunol       Date:  2016-05-12       Impact factor: 7.561

Review 7.  Revisiting Drug Development Against the Neglected Tropical Disease, Amebiasis.

Authors:  Manish T Shrivastav; Zainab Malik
Journal:  Front Cell Infect Microbiol       Date:  2021-02-24       Impact factor: 5.293

Review 8.  Lipids in Entamoeba histolytica: Host-Dependence and Virulence Factors.

Authors:  Silvia Castellanos-Castro; Jeni Bolaños; Esther Orozco
Journal:  Front Cell Infect Microbiol       Date:  2020-03-10       Impact factor: 5.293

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.